Company Email Format Management

DIOSynVax

Biotechnology Research Cambridge, Cambridgeshire, United Kingdom 23 employees

Employees: 23
Contacts: 1
Emails: 1

diosvax.com LinkedIn Crunchbase

DIOSynVax Overview

Headquarters: Cambridge, Cambridgeshire, United Kingdom
Website: diosvax.com
Industry: Biotechnology Research
Employees: 23
Founded: 2017
Funding: 42.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

in Clinical Vaccine Development will be instrumental as DIOSynVax advances through clinical Proof of Concept (PoC) of its groundbreaking technology that leverages computational biology to design next-generation vaccines with broad protective capabilities.

About DIOSynVax

DIOSVax is a biotech startup working to revolutionise the way humanity protects itself from infectious disease and emerging pathogens. The company is named after its core technology, DIOSynVax (Digitally designed, Immune Optimised Selected and Synthesized Vaccines), a new system that will significantly accelerate vaccine development and achieve dramatic improvements to the protection against emerging and re-emerging pathogens.

DIOSynVax Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage

DIOSynVax Org Chart

Sample employees and titles

Name	Title	Location	Contact
Nigel Temperton	Professor of Molecular Virology		View
Ronald Moss	Chief Executive Officer		View
David Moss	Senior Project Manager at Diosynvax		View
Jannine Ruby	Office Manager at Diosynvax	Greater Cambridge Area, United Kingdom	Email